» Articles » PMID: 36309664

Estimating the Burden of Diseases Attributable to Lead Exposure in the North Africa and Middle East Region, 1990-2019: a Systematic Analysis for the Global Burden of Disease Study 2019

Abstract

Background: Lead exposure (LE) and its attributable deaths and disability-adjusted life years (DALYs) have declined in the recent decade; however, it remains one of the leading public health concerns, particularly in regions with low socio-demographic index (SDI) such as the North Africa and Middle East (NAME) region. Hence, we aimed to describe the attributable burden of the LE in this region.

Methods: Data on deaths, DALYs, years of life lost (YLLs), and years lived with disability (YLDs) attributable to LE in the NAME region and its 21 countries from 1990 to 2019 were extracted from the Global Burden of Disease (GBD) 2019 study.

Results: In 2019, the age-standardized death and DALY rates attributable to LE were 23.4 (95% uncertainty interval: 15.1 to 33.3) and 489.3 (320.5 to 669.6) per 100,000 in the region, respectively, both of which were higher among men than women. The overall age-standardized death and DALY rates showed 27.7% and 36.8% decreases, respectively, between 1990 and 2019. In this period, Bahrain, the United Arab Emirates, and Turkey had the highest decreases in the age-standardized death and DALY rates, while Afghanistan, Egypt, and Yemen had the lowest ones. Countries within high SDI quintile had lower attributable burden to LE compared with the low SDI quintile. Cardiovascular diseases and chronic kidney diseases accounted for the 414.2 (258.6 to 580.6) and 28.7 (17.7 to 41.7) LE attributable DALYs per 100,000 in 2019, respectively. The attributable YLDs was 46.4 (20.7 to 82.1) per 100,000 in 2019, which shows a 25.7% reduction (-30.8 to -22.5%) over 1990-2019.

Conclusions: The overall LE and its attributed burden by cause have decreased in the region from 1990-2019. Nevertheless, the application of cost-effective and long-term programs for decreasing LE and its consequences in NAME is needed.

Citing Articles

Polydatin Mitigates Lead-Induced Nephropathy by Modulating Oxidative Stress, Inflammation, and the AMPK/AKT/Nrf2 Pathway in Rats.

Dahran N, Alobaidy M, Owaydhah W, Soubahi E, Eisa A, Nasreldin N Biol Trace Elem Res. 2025; .

PMID: 40085304 DOI: 10.1007/s12011-025-04570-9.


Spatiotemporal patterns of rheumatic heart disease burden attributable to high systolic blood pressure, high sodium diet, and lead exposure (1990 to 2019): a longitudinal observational study.

Zhang Y, Zhang J, Liu Y, Zhou Y, Ye L, Chen K Front Nutr. 2024; 11:1419349.

PMID: 39391682 PMC: 11466049. DOI: 10.3389/fnut.2024.1419349.


The association between heavy metal exposure and obesity: A systematic review and meta-analysis.

Zangiabadian M, Ghaffari Jolfayi A, Nejadghaderi S, Amirkhosravi L, Sanjari M J Diabetes Metab Disord. 2024; 23(1):11-26.

PMID: 38932800 PMC: 11196503. DOI: 10.1007/s40200-023-01307-0.


Chronic lead exposure and burden of cardiovascular disease during 1990-2019: a systematic analysis of the global burden of disease study.

Dang P, Tang M, Fan H, Hao J Front Cardiovasc Med. 2024; 11:1367681.

PMID: 38655496 PMC: 11035890. DOI: 10.3389/fcvm.2024.1367681.


Unveiling the lead exposure attributed burden in Iran from 1990 to 2019 through the lens of the Global Burden of Disease study 2019.

Karimi H, Mahdavi S, Moghaddam S, Abbasi-Kangevari M, Soleimani Z, Esfahani Z Sci Rep. 2024; 14(1):8688.

PMID: 38622232 PMC: 11018826. DOI: 10.1038/s41598-024-58823-z.


References
1.
Caravanos J, Carrelli J, Dowling R, Pavilonis B, Ericson B, Fuller R . Burden of disease resulting from lead exposure at toxic waste sites in Argentina, Mexico and Uruguay. Environ Health. 2016; 15(1):72. PMC: 4918194. DOI: 10.1186/s12940-016-0151-y. View

2.
Mason L, Harp J, Han D . Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int. 2014; 2014:840547. PMC: 3909981. DOI: 10.1155/2014/840547. View

3.
Aoki Y, Brody D, Flegal K, Fakhouri T, Axelrad D, Parker J . Blood Lead and Other Metal Biomarkers as Risk Factors for Cardiovascular Disease Mortality. Medicine (Baltimore). 2016; 95(1):e2223. PMC: 4706249. DOI: 10.1097/MD.0000000000002223. View

4.
Lin J, Lin-Tan D, Li Y, Chen K, Huang Y . Low-level environmental exposure to lead and progressive chronic kidney diseases. Am J Med. 2006; 119(8):707.e1-9. DOI: 10.1016/j.amjmed.2006.01.005. View

5.
. The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990-2017. Lancet Psychiatry. 2019; 7(2):148-161. PMC: 7029418. DOI: 10.1016/S2215-0366(19)30475-4. View